In.Pact SFA II

Randomized Trial of IN.PACT (Paclitaxel) Admiral Drug-Eluting Balloon (DEB) vs. Standard Percutaneous Transluminal Angioplasty (PTA) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)

In.Pact SFA II [NCT01566461]

Description: The purpose of the study is to demonstrate the safety and efficacy of the IN.PACT Admiral drug-eluting balloon in comparison to any standard balloon for treatment of peripheral arterial disease (PAD) in the superficial femoral artery and proximal popliteal artery.

Device: IN.PACT Admiral Drug-Eluting Balloon; Device: Standard angioplasty balloon

Primary Investigator: Hunter

Drug/Device Information
Admiral DEB Paclitaxel-Eluting Percutaneous Transluminal Angioplasty vs Standard Balloon Percutaneous Tranluminal Angioplasty
Randomized 2:1
Medtronic